Efficacy of Chaowei Zhikangyin in treatment of rat model of non-alcoholic fatty liver disease
-
摘要:
目的观察超微脂康饮对实验性非酒精性脂肪肝(NAFLD)大鼠模型的疗效。方法 SD大鼠高脂饮食饲养6周后诱导非酒精性脂肪肝大鼠模型,肝脏病理切片证实造模成功;造模大鼠50只随机分为5组,超微脂康饮(低、中、高剂量)组给予相应剂量的超微脂康饮灌胃,壳脂胶囊组给予壳脂胶囊混悬液,模型组及空白组灌服蒸馏水,除空白组外,其余组仍予高脂饮食。6周后分别检测各组的肝功能、血脂、肝脂及肝脏组织学改变。各组之间比较采用单因素方差分析。结果超微脂康饮各组血清ALT、AST、肝组织脂质(TC、TG)等方面均优于模型组,差异均有统计学意义(P值均<0.05),超微脂康饮中,低剂量组血清TG、TC显著优于模型组,差异均有统计学意义(P值均<0.05);超微脂康饮各组血清alt、ast、肝组织tc与壳脂胶囊组比差差异无统计学意义(p值均>0.05)。模型组及超微脂康饮各组均存在不同程度的肝脏炎症活动度,但与模型组比较,超微脂康饮各组、壳脂胶囊组大鼠的肝脏炎症活动度均有不同程度的改善(P值均<0.05),而壳脂胶囊组较超微脂康饮各组改善稍明显(P值均<0.05)。结论超微脂康饮能改善N...
-
关键词:
- 脂肪肝 /
- 超微脂康饮 /
- 大鼠,sprague-dawley
Abstract:Objective To observe the efficacy of Chaowei Zhikangyin in the treatment of the rat model of non-alcoholic fatty liver disease(NAFLD).Methods A rat model of NAFLD was established by feeding 50 Sprague-Dawley rats with high-fat diet for 6 weeks and was confirmed by liver pathological examination.Then,the model rats were randomly divided into five groups:low-,medium-,and high-dose Chaowei Zhikangyin groups(given Chaowei Zhikangyin by gavage),Kezhi capsule treatment group(given a suspension of Kezhi capsules),and model group(orally given distilled water).In addition,control rats were fed with normal diet and then treated with distilled water.Six weeks later,the liver function,blood lipids,liver lipids,and liver histology were examined.Results All Chaowei Zhikangyin groups were superior to the model group in terms of alanine aminotransferase,aspartate aminotransferase,total cholesterol(TC),and triglyceride(TG) in serum and TC and TG in liver tissues(P < 0.05),but there were no significant differences between these Chaowei Zhikangyin groups and Kezhi capsule treatment group(P > 0.05).Different degrees of liver inflammation was observed in the model group and Chaowei Zhikangyin groups; however,the Chaowei Zhikangyin groups and Kezhi capsule treatment group had reduced liver inflammation compared with the model group(P < 0.05),and the Kezhi capsule treatment group showed a significantly more improvement than these Chaowei Zhikangyin groups(P < 0.05).Conclusion Chaowei Zhikangyin can improve liver function,reduce blood lipids,and inhibit liver inflammation in rats with NAFLD,and it has comparable efficacy to Kezhi capsules.This therapy can be used for treating NAFLD.
-
Key words:
- fatty liver /
- AMD-zhikangyin /
- rats,sprague-dawley
计量
- 文章访问数: 2563
- HTML全文浏览量: 12
- PDF下载量: 537
- 被引次数: 0